The global oral solid dosage pharmaceutical formulation market is poised for remarkable expansion, with projections indicating a growth from USD 629,582.6 million in 2024 to USD 895,636.0 million by ...
Thibaut Mongon; Chief Executive Officer, Director; Kenvue Inc Paul Ruh; Chief Financial Officer; Kenvue Inc Bonnie Herzog; Analyst; Goldman Sachs Anna Lizzul; Analyst; Bank of America Andrea Teixeira; ...